The money will be split by small biotech companies that might struggle to pay for clinical trials comparing new vaccines against those now available.
Author: Karen Weintraub, USA TODAY
Another step toward using animal organs: Pig kidney sustains brain-dead man for a month
Pigs might help solve the organ transplant crisis if researchers can make the process safe enough. Preventing rejection in brain-dead subjects is a step toward that goal.
The next pandemic could spring from the US meat supply, new report finds
While Americans may think a pandemic like COVID can’t start here, researchers say lax regulation of livestock and wild animals make it a real risk.
How big a role does chance play in health outcomes? New book says more than you may think.
In his new book, ‘Random Acts of Medicine,’ Dr. Anupam Jena recounts studies that look at the role chance plays in medicine. We chatted with him.
What’s to blame for certain cancer outcomes? New studies confirm: sex matters
A pair of studies shows the Y chromosome, which characterizes males, plays a key role in some cancers.
Should a baby’s genes be sequenced at birth? Study finds potential life-saving benefits
More than 10% of babies were found to have ‘actionable’ genetic mutations when screened at birth. The findings offered parents action items as well.
A short supply of cancer drugs has doctors and patients worried: ‘We’re at a critical juncture’
More than a dozen cancer drugs have been in shortage in recent months, putting patients, particularly women, at risk.
Study finds brain ‘signature’ for chronic pain, which could improve diagnosis, treatment
Arthritis and other sources of chronic pain has a fundamentally different brain signature than the acute pain of a stubbed toe, study finds.
US should have attacked COVID like a foreign invasion, experts say. Have we learned any lessons?
A group of more than 30 experts has written a book that examines what went wrong in how the United States responded to the COVID-19 pandemic.
Another COVID booster is now approved for older people and those at high risk
The FDA on Tuesday said people over 65 and those at high risk for coronavirus can get a second COVID booster shot. What to know about the vaccine.